The investments will aid in deeper integration of NJ Bio’s customer-facing services and focused development of Aruka’s proprietary pipeline through potential partnerships. Both the transactions will be funded through internal accruals.
The investments will aid in deeper integration of NJ Bio’s customer-facing services and focused development of Aruka’s proprietary pipeline through potential partnerships. Both the transactions will be funded through internal accruals.
<iframe src="https://hindustansphere.com/embed/cluster/794f70900fb72201374eac10f1f07e6929ea654b" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Cohance Lifesciences investing $18 million in NJ Bio, Aruka Bio to sharpen focus on ADC"></iframe>
